About Avisi Technologies
Avisi Technologies is a Technology company based in Philadelphia (United States) founded in 2017 by Brandon Kao and Rui Jing Jiang. Nano-materials for glaucoma treatment implants are developed. It operates in the Technology, Healthcare, and Chemicals & Materials sectors. Avisi Technologies has raised $15.7 million across 5 funding rounds from investors including Good Growth Capital, Ben Franklin Technology Partners and LSG Investments. Its chief executive, as recorded, is Rui Jing Jiang. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is Avisi Technologies, Inc. Its competitors include Glaukos, Novavax and SINTX; 2 of its 3 listed competitors have raised funding.
Company details
Avisi Technologies was founded in 2017 in Philadelphia, United States. Nano-materials are developed by the company within the medical technology sector. An ultrathin nanoplate made of alumina is created as implant material for mid to late-stage glaucoma treatment. This work is conducted in collaboration with the University of Pennsylvania. A platform is provided to support these material developments and applications.
- Headquarters Philadelphia, United States
- Founders Brandon Kao, Rui Jing Jiang
- SectorsTechnologyHealthcare Chemicals & Materials
- Website avisitech.com
- Social LinkedIn Facebook YouTube
- Legal Name Avisi Technologies, Inc.
- Total Equity Funding$15.7M (USD)
in 5 rounds
- Latest Funding Round$10.7M (USD), Series A
Feb 2026
- InvestorsGood Growth Capital
& 16 more
Apps and channels of Avisi Technologies
its YouTube channel Avisi Technologies has 5 subscribers.
Funding Insights of Avisi Technologies
Avisi Technologies has successfully raised a total of $15.7M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $10.7 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.7M
- Total Rounds 5
- Last Round Series A — $10.7M
- First Round $225,000
(Jul 2019)
- Investors Count 17
All 5 funding rounds of Avisi Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2026 | $10.7M | Series A | – | MedVenture Partners | |
| Jan 2023 | $4M | Series A | – | Accanto Partners | |
| Jan 2021 | $1M | Seed | – | MedTech Innovator | – |
| Sep 2020 | $1M | Grant | – | – | |
| Jul 2019 | $225,000 | Grant | – | – |
17 investors in total: 17 institutional.
Investors in Avisi Technologies
Avisi Technologies has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include Good Growth Capital, Ben Franklin Technology Partners and LSG Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in life sciences technologies. | lsgpa.com | Harrisburg, United States | ||
| accantopartners.com | ||||
Investment and support are provided for Pennsylvania's tech-based companies. | 1983 | benfranklin.org | State College, United States | |
A family office focused on long-term value investments. | 2014 | quakercap.com | Pittsburgh, United States | |
Early-stage investments are made in life sciences and technologies. | 2017 | goodgrowthvc.com | Charleston, United States | |
Venture capital investments are made in early-stage scaling companies. | mountainstatecapital.com | Morgantown, United States | ||
Life sciences startups are funded by a non-profit angel network. | lifescienceangels.com | Sunnyvale, United States | ||
Venture capital investing with a focus on diversity and inclusion in the ecosystem. | gaingels.com | |||
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide. | medtechinnovator.org | |||
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States |
Investor details for Avisi Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Avisi Technologies
20 people are tracked at Avisi Technologies (3 in leadership, 14 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Brandon Kao | Co-Founder | Leadership |
Rui Jing Jiang | Co-Founder & CEO | Leadership |
Georgia Griggs | Principal Engineer, Site Head | Leadership |
Gary Pruden | Director | Board & advisors |
Catherine Mohr | Director | Board & advisors |
Paul Norris | Director | Board & advisors |
Eydie Miller-Ellis | Board Member | Board & advisors |
Richard A. Lewis | Board Member | Board & advisors |
Iqbal K. Ahmed | Board Member | Board & advisors |
Ehsan Sadri | Board Member | Board & advisors |
Jonathan S. Myers | Board Member | Board & advisors |
Vance Thompson | Board Member | Board & advisors |
Vivian Lee | Board Member | Board & advisors |
Georges Durr | Board Member | Board & advisors |
Barry Cheskin | Board Member | Board & advisors |
Samuel Nicaise | Board Member | Board & advisors |
Thomas A. Barbolt | Board Member | Board & advisors |
Jeff Emery | SVP of R&D & Operations | Team |
Seth Harrington | Business Operations Associate | Team |
Jagraj Singh | Manager, Quality Engineering | Team |
Complete people profiles for Avisi Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Avisi Technologies
3 dated milestones of Avisi Technologies across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Avisi Technologies is founded.
- Funding First funding round of $225K.
- Funding Latest funding round, Series A, of $10.7M.
Competitors of Avisi Technologies
Avisi Technologies has 3 listed competitors in our database, 2 of them funded. They include Glaukos, Novavax and SINTX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| glaukos.com | 2001 | Laguna Hills, United States | $117.57M | 907 | Developer of implants to treat glaucoma | |
| novavax.com | 1987 | Gaithersburg, United States | 184 | Novel vaccines are developed using nanoparticle and matrix adjuvant technology. | ||
| sintx.com | 1996 | Salt Lake, United States | $22.13M | 41 | Silicon nitride medical devices are manufactured for interbody fusion. |
Detailed competitors of Avisi Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Avisi Technologies
The website of Avisi Technologies (avisitech.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▲ 103.2% vs previous month
Top companies in Nanotechnology
3 companies that operate in the same segment as Avisi Technologies (Nanotechnology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Avisi Technologies
Complete news archive for Avisi Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avisi Technologies
Avisi Technologies was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Avisi Technologies is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Rui Jing Jiang is the CEO of Avisi Technologies, as recorded in our data. They have also founded this company.
Avisi Technologies is a funded company, having raised a total of $15.7M across 5 funding rounds to date. The company's 1st funding round was a Grant of $225K, raised on Jul 2019.
Avisi Technologies was founded in 2017 in Philadelphia, United States. Nano-materials are developed by the company within the medical technology sector. An ultrathin nanoplate made of alumina is created as implant material for mid to late-stage glaucoma treatment. This work is conducted in collaboration with the University of Pennsylvania. A platform is provided to support these material developments and applications.
Avisi Technologies has 17 investors. Key investors include Good Growth Capital, Ben Franklin Technology Partners, LSG Investments, Accanto Partners, and Quaker Capital Investments.
Avisi Technologies operates through Avisi Technologies, Inc..